Adrian J R Smith Net Worth

The estimated Net Worth of Adrian J R Smith is at least 122 千$ dollars as of 19 November 2012. Adrian Smith owns over 15,000 units of RTI Surgical stock worth over 57,227$ and over the last 17 years Adrian sold RTIX stock worth over 64,650$.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Adrian Smith RTIX stock SEC Form 4 insiders trading

Adrian has made over 1 trades of the RTI Surgical stock since 2012, according to the Form 4 filled with the SEC. Most recently Adrian sold 15,000 units of RTIX stock worth 64,650$ on 19 November 2012.

The largest trade Adrian's ever made was selling 15,000 units of RTI Surgical stock on 19 November 2012 worth over 64,650$. On average, Adrian trades about 1,364 units every 0 days since 2008. As of 19 November 2012 Adrian still owns at least 18,225 units of RTI Surgical stock.

You can see the complete history of Adrian Smith stock trades at the bottom of the page.

What's Adrian Smith's mailing address?

Adrian's mailing address filed with the SEC is 119 Springline Dr, Vero Beach, FL 32963, USA.

Insiders trading at RTI Surgical

Over the last 21 years, insiders at RTI Surgical have traded over 71,830$ worth of RTI Surgical stock and bought 390,515 units worth 1,973,594$ . The most active insiders traders include Jeffrey C Lightcap、Mark Stolper、Terry M. Rich. On average, RTI Surgical executives and independent directors trade stock every 138 days with the average trade being worth of 62,561$. The most recent stock trade was executed by Jonathon M Singer on 12 December 2018, trading 50,000 units of RTIX stock currently worth 214,000$.

What does RTI Surgical do?

RTI Surgical Holdings, Inc. engages in the provision of biologic, metal, and synthetic-based surgical implants. It offers implants in the following categories: extremities, orthobiologics, spine, sports medicine, and surgical specialties. The company was founded in February 1998 and is headquartered in Deerfield, IL.

Complete history of Adrian Smith stock trades at RTI Surgical

RTI Surgical executives and stock owners

RTI Surgical executives and other stock owners filed with the SEC include:

• Jonathon Singer,
  Chief Financial Officer, Chief Operating Officer
• John Varela,
  Executive Vice President - Global Operations
• Olivier Visa,
  Vice President - OEM, Sports and Donor Services
• Shirley Weis,
  Independent Director
• Thomas McEachin,
  Independent Director
• Mark Stolper,
  Lead Independent Director
• Paul Thomas,
  Independent Director
• Nicholas Valeriani,
  Independent Director
• Pawel Lewicki,
  Director
• Scott Durall,
  Chief Commercial Officer
• Bryan Cornwall,
  Executive Vice President - Research and Clinical Affairs
• Stuart Simpson,
  Chairman of the Board
• Molly Poarch,
  Director, Corporate Communications & Investor Relations
• Jeffrey Lightcap,
  Independent Director
• Brian Kushner,
  Director
• Ryan Bartolucci,
  Vice President - Finance, Corporate Controller
• Terry Rich,
  President, Chief Executive Officer, Director
• Lyle P. Luedeman,
  
• Dean H Bergy,
  Director
• Street Healthcare Partners ...,
  
• Christopher R Sweeney,
  Director
• Curtis M Selquist,
  Director
• Peter F Gearen,
  Director
• Brian K Hutchison,
  Chairman, President and CEO
• Camille Farhat,
  Chief Executive Officer
• Robert P Jordheim,
  Executive Vice President/CFO
• Roger W Rose,
  Vice President Donor Services
• Johannes Wynand Louw,
  Vice President Finance
• Kevin D Brandt,
  EVP CCO-Domestic Direct
• Joshua H De Rienzis,
  General Counsel
• Philip R Chapman,
  Director
• Ned Hoye Villers,
  Director
• Adrian J R Smith,
  Director
• Caroline A Hartill,
  V.P. Quality Assurance
• Julianne M Bowler,
  Director
• Roy D Crowninshield,
  Director
• Gregory P Rainey,
  Director
• Neal B Freeman,
  Director
• Michael J La Prade,
  Vice President
• Holdings Inc Zimmer,
  10% owner
• Roderick N Allen,
  Vice President
• David J Simpson,
  Director
• Guy L Mayer,
  President
• Michael J Odrich,
  Director
• Lee Robert Jr Johnston,
  Vice President
• Udo Henseler,
  Director
• Christie J Blakely,
  Vice President
• Robert J Lane,
  Vice President
• Tara Leigh Zerby,
  VP, Xenograft Technologies
• Carolyn Shaffer,
  Vice President, Human Resource
• Thomas F Rose,
  Vice President and CFO
• Michael T Manley,
  Director
• Louis E Barnes,
  Vice President-Cardiovascular
• Charles Randal Mills,
  V.P. of Business Development
• William Melendez,
  Vice President, Research & Dev
• Jeffrey Michael Schumm,
  Vice Pres. and General Counsel
• Joseph W Condon,
  Vice President-Operations